Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy
Condition: Liver Cancer Interventions: Drug: Bevacizumab; Drug: Atezolizumab; Drug: Sofosbuvir; Drug: Velpatasvir; Drug: Voxilaprevir; Drug: Ribavirin Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Antiviral Therapy | Avastin | Cancer | Cancer & Oncology | Carcinoma | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Immunotherapy | Liver Cancer | Research